HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Prescription of fondaparinux in hospitalised patients.

Abstract
Fondaparinux is an antithrombotic agent with unique properties that may offer benefit to patients beyond the current approved indications. To explore the off-label use versus approved use of fondaparinux, we initiated a single-center registry of fondaparinux use. During the 25-month study period, 219 patients were prescribed fondaparinux: 157 (71.7%) for prophylaxis and 62 (28.3%) patients for the treatment of thrombosis. When fondaparinux was used for prophylaxis in our registry, 94% of patients had documentation of heparin-induced thrombocytopenia (HIT). Fondaparinux warrants further evaluation in patients with HIT or suspected HIT. In the meantime, its off-label use may exceed its use for FDA-approved indications.
AuthorsSteven Baroletti, Matthew Labreche, Matthew Niles, John Fanikos, Samuel Z Goldhaber
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 101 Issue 6 Pg. 1091-4 (Jun 2009) ISSN: 0340-6245 [Print] Germany
PMID19492152 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Polysaccharides
  • Heparin
  • fondaparinux
Topics
  • Adult
  • Aged
  • Drug Prescriptions
  • Female
  • Fibrinolytic Agents (administration & dosage, adverse effects)
  • Heparin (administration & dosage, adverse effects)
  • Hospitals
  • Humans
  • Male
  • Middle Aged
  • Orthopedic Procedures
  • Perioperative Care
  • Polysaccharides (administration & dosage, adverse effects)
  • Pulmonary Embolism (drug therapy)
  • Registries
  • Risk Factors
  • Thrombocytopenia (chemically induced, drug therapy)
  • Treatment Outcome
  • Venous Thromboembolism (drug therapy, surgery)
  • Venous Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: